BlackRock, Inc.

Position in DNTH — Dianthus Therapeutics, Inc. /DE/

CIK 2012383 New York, NY

Position in DNTH

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$401,990,159

+$135,485,171 QoQ

Shares Held

4,123,822

+29.9% QoQ

Ownership

7.37%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

of 269 holders

Holding Since

Sep 2024

8 quarters on record

Voting authority Sole 97% Shared 0% None 3%

Healthcare · as of Jun 30, 2026

BlackRock, Inc. holds $85,603,777,939 across 474 Biotechnology names. DNTH ranks #47 (0.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	24,109,373	$11,975,848,839
2	REGN	Regeneron Pharmaceuticals, Inc.	9,113,506	$5,682,635,520
3	ALNY	Alnylam Pharmaceuticals, Inc.	10,907,675	$3,283,537,392
4	RVMD	Revolution Medicines, Inc.	13,695,790	$2,564,947,540
5	MRNA	Moderna, Inc.	30,599,409	$2,142,876,602
6	INCY	Incyte Corp	18,032,718	$2,044,188,902
7	CYTK	Cytokinetics Inc	20,094,362	$1,711,838,691
8	ROIV	Roivant Sciences Ltd.	48,236,091	$1,707,075,250

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$401,990,159	4,123,822	+29.9%	Shares	Sole	2026-08-07
2026-06-30	$341,586,101	3,504,166	—	Shares	Sole	2026-07-28
2026-03-31	$266,504,988	3,175,703	+65.8%	Shares	Sole	2026-05-13
2025-12-31	$78,926,870	1,915,236	+42.9%	Shares	Sole	2026-02-12
2025-09-30	$52,732,577	1,340,091	-1.4%	Shares	Sole	2025-11-12
2025-06-30	$25,314,087	1,358,781	-15.9%	Shares	Sole	2025-08-12
2025-03-31	$29,310,627	1,615,801	-2.1%	Shares	Sole	2025-05-02
2024-12-31	$35,989,225	1,650,882	+0.4%	Shares	Sole	2025-02-07
2024-09-30	$45,035,141	1,644,819	—	Shares	Sole	2024-11-13
No filing history on record for this holder in this stock.